Skip to main content

Table 2 Overview on the number of significantly enriched gene set for different background datasets for each analyzed trait in the case study

From: PROTEOMAS: a workflow enabling harmonized proteomic meta-analysis and proteomic signature mapping

Trait

# Significantly altered GO terms

# Significantly altered KEGG pathways

# Significantly altered REACTOME pathways

# Significantly altered HALLMARK sets

Lung cancer

1462

46

181

35

IPA

1065

42

189

22

CNT NM-400

396

11

44

12

COPD

312

6

110

8

Drug

1739

47

329

25

CB

19

0

6

0

Co NM

6

1

7

2

Fe NM

80

1

18

0

FeCo NM

127

1

30

0

CNT NM-403

201

2

13

3

Ag NM

185

6

21

5

Au NM

417

10

93

9

Other CNT

300

6

79

8

CuO NM

300

3

65

9

ND

145

1

10

1

LPS

140

4

19

7

QD

276

8

66

8

TiO2

696

33

171

17

Virus

446

21

73

16